Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Brunner

Clinical Cardiac Electrophysiology Grand Rapids, MI Medical Doctor

NPI 1659545440 CMS profile 30062

2900 Bradford St Ne, Grand Rapids, MI 49525

Open in the dashboard

General payments

$11,805

135 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Brunner of Grand Rapids, MI is reported in the CMS Open Payments database as having received $11,805 across 135 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 38th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $794 13
2024 General $4,583 40
2023 General $1,721 24
2022 General $2,279 19
2021 General $1,102 12
2020 General $321 11
2019 General $1,005 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Brunner
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Michael Brunner were reported at $794. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Michael Brunner Clinical Cardiac Electrophysiology median Middle half National median
2019 $1,005 $2,361 $585–$8,260 $163
2020 $321 $993 $247–$4,351 $114
2021 $1,102 $1,185 $326–$4,739 $132
2022 $2,279 $2,073 $554–$6,789 $149
2023 $1,721 $2,568 $759–$8,159 $160
2024 $4,583 $2,557 $703–$7,403 $164
2025 $794 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $5,046 41 payments
  2. Medtronic, Inc. $3,463 35 payments
  3. Biosense Webster, Inc. $1,018 12 payments
  4. Boston Scientific Corporation $722 8 payments
  5. Medtronic Vascular, Inc. $257 10 payments
  6. Atricure, Inc. $240 3 payments
  7. iRhythm Technologies, Inc. $173 1 payment
  8. Acutus Medical, Inc. $161 1 payment
  9. Cardiva Medical, Inc. $158 4 payments
  10. Janssen Pharmaceuticals, Inc $152 9 payments
  11. Other $415 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,701 118 payments
  2. Travel and Lodging $3,104 17 payments
Products named General payments · program years 2019–2025
  1. AVEIR Cardiac Rhythm Management $1,759 11 payments
  2. AVEIR Cardiac Rhythm Management $1,455 10 payments
  3. EVERA MRI XT DR SURESCAN $1,008 5 payments
  4. Carto 3 $661 8 payments
  5. NA $535 6 payments
  6. Micra $443 7 payments
  7. CryoConsole $388 4 payments
  8. ENSITE $365 3 payments
  9. Confirm Rx $347 4 payments
  10. AURORA EV-ICD MRI SURESCAN $297 3 payments
  11. Other $4,365 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

2,521

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$1,294,738

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

53.2%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 922 $1,042,681
Xarelto Rivaroxaban Brand 146 $180,411
Dofetilide Generic 77 $15,640
Metoprolol Succinate Generic 407 $14,872
Flecainide Acetate Generic 236 $14,057
Amiodarone Hcl Generic 342 $7,497
Dabigatran Etexilate Dabigatran Etexilate Mesylate Brand 15 $6,904
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 173 $6,292
Mexiletine Hcl Generic 19 $2,824
Sotalol Sotalol Hcl Brand 73 $1,841

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$93,039

Medicare's payments for the services billed

Medicare patients

900

Average age 76

Services billed

2,104

423 women, 477 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 63%
Heart failure 51%
Arthritis 51%
Ischemic heart disease 48%
Chronic kidney disease 41%
Diabetes 35%
Depression 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

135 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record